lupeol
Small moleculeexperimental
Lupeol is a pharmacologically active pentacyclic triterpenoid. It has several potential medicinal properties, like anticancer and anti-inflammatory activity. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT02152865)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLupeol ↗
Also known as
- lup-20(29)-en-3beta-ol
- lup-20(29)-en-3-ol
- lup-20(29)-ene-3alpha-ol
- lupeol
- lupeol
- lupeol
- lupeol
- lupeol, (3alpha)-isomer
- lupeol, (3beta,18beta,19beta)-isomer
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02205892 | N/A | Aug 1, 2014 | Seoul National University |
| NCT02152865 | N/A | Dec 1, 2009 | Seoul National University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 2 | 2 | 1 | 2009 |
1 organizations
Page 1 / 1